Shivalik Rasayan Ltd (IN:SHIVALIK)
:SHIVALIK
Want to see IN:SHIVALIK full AI Analyst Report?
SHIVALIK Stock Chart & Stats
₹358.75
-₹13.65(-1.86%)
At close: 4:00 PM EST
₹358.75
-₹13.65(-1.86%)
Day’s Range― - ―
52-Week Range₹207.70 - ₹652.75
Previous CloseN/A
Volume18.40K
Average Volume (3M)1.25K
Market Cap
₹3.41B
Enterprise Value₹4.29B
Total Cash (Recent Filing)₹468.39M
Total Debt (Recent Filing)₹1.00B
Price to Earnings (P/E)29.2
Beta1.09
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.13%
Share Statistics
EPS (TTM)9.00
Shares Outstanding15,750,365
10 Day Avg. Volume987
30 Day Avg. Volume1,247
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.94
P/FCF Ratio-5.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent mid-single to mid-teens annual revenue growth from 2021–2026 demonstrates resilient end-market demand and expanding commercial traction in APIs and specialty chemicals. Durable top-line gains create scale benefits, support fixed-cost absorption, and provide a stable base for selective reinvestment and customer commitments.
Conservative Balance SheetLow leverage and rising equity give the company financial flexibility to fund working capital, manage cyclical demand, or pursue targeted capex without large refinancing risk. A conservatively levered balance sheet supports operational continuity and strategic optionality over the medium term, reducing solvency risk.
Specialty Chemical / API MixA product mix centered on APIs, intermediates and specialty chemicals serves structural pharmaceutical and industrial demand and tends to involve long-term customer relationships and repeat orders. This concentration supports steady volumes, higher technical barriers to entry, and potential pricing resilience versus commodity segments.
Bears Say
Negative Cash ConversionPersistent negative operating and free cash flow signal working-capital stress and poor cash conversion despite revenue growth. This increases reliance on financing or reserves to fund operations and investment, constrains discretionary spend (capex/dividends), and raises execution risk if cash conversion doesn't improve.
Declining EarningsA roughly 30% decline in EPS reflects materially weaker profitability even as revenue rose. Falling earnings reduce internal funding for growth or returns to shareholders and point to margin pressure or cost challenges that undermine earnings quality and long-term cash generation capacity.
Weak Return On EquityROE falling to low single-digits while equity has grown suggests the company is less efficient at converting capital into profits. Persistent low ROE implies capital allocation or margin issues that, if unresolved, limit the firm's ability to generate attractive shareholder returns and justify further equity buildup.
Shivalik Rasayan Ltd News
SHIVALIK FAQ
What was Shivalik Rasayan Ltd’s price range in the past 12 months?
Shivalik Rasayan Ltd lowest stock price was ₹207.70 and its highest was ₹652.75 in the past 12 months.
What is Shivalik Rasayan Ltd’s market cap?
Shivalik Rasayan Ltd’s market cap is ₹3.41B.
When is Shivalik Rasayan Ltd’s upcoming earnings report date?
Shivalik Rasayan Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 46 days.
How were Shivalik Rasayan Ltd’s earnings last quarter?
Shivalik Rasayan Ltd released its earnings results on May 27, 2026. The company reported ₹2.87 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.87.
Is Shivalik Rasayan Ltd overvalued?
According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued.
Does Shivalik Rasayan Ltd pay dividends?
Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.13%. See more information on Shivalik Rasayan Ltd dividends here
What is Shivalik Rasayan Ltd’s EPS estimate?
Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shivalik Rasayan Ltd have?
Shivalik Rasayan Ltd has 15,750,365 shares outstanding.
What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?
Shivalik Rasayan Ltd reported an EPS of ₹2.87 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.956%.
Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?
Currently, no hedge funds are holding shares in IN:SHIVALIK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shivalik Rasayan Ltd
Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.
Technical Analysis
Bodal Chemicals Limited
―
DIC India Limited
―
Mangalam Organics Ltd
―
Poddar Pigments Limited
―
Shankar Lal Rampal Dye-Chem Ltd.
―